Manzoor F, Tsurgeon C, Gupta V
Bioengineering (Basel). 2025; 12(1).
PMID: 39851330
PMC: 11760846.
DOI: 10.3390/bioengineering12010056.
Andrieu T, Duo A, Duempelmann L, Patzak M, Saner F, Skrabalova J
Int J Mol Sci. 2024; 25(23).
PMID: 39684780
PMC: 11641628.
DOI: 10.3390/ijms252313071.
Vashisht V, Vashisht A, Mondal A, Woodall J, Kolhe R
Curr Issues Mol Biol. 2024; 46(11):12527-12549.
PMID: 39590338
PMC: 11592618.
DOI: 10.3390/cimb46110744.
Liang G, Yin H, Ding F
GEN Biotechnol. 2024; 2(5):384-398.
PMID: 39544230
PMC: 11562938.
DOI: 10.1089/genbio.2023.0032.
Lyu Y, Lin S, Wu H, Li Z
Bioinformatics. 2024; 40(9).
PMID: 39226185
PMC: 11415828.
DOI: 10.1093/bioinformatics/btae537.
High-throughput proteomics-guided biomarker discovery of hepatocellular carcinoma.
Shin D, Kim Y, Park J, Kim Y
Biomed J. 2024; 48(1):100752.
PMID: 38901798
PMC: 11743302.
DOI: 10.1016/j.bj.2024.100752.
Potential of Synbiotics and Probiotics as Chemopreventive Agent.
Chin K, Khoo S, Paul R, Luang-In V, Lam S, Ma N
Probiotics Antimicrob Proteins. 2024; 16(6):2085-2101.
PMID: 38896220
DOI: 10.1007/s12602-024-10299-z.
Technologies to Study Genetics and Molecular Pathways.
Grunert M, Dorn C, Dopazo A, Sanchez-Cabo F, Vazquez J, Rickert-Sperling S
Adv Exp Med Biol. 2024; 1441:435-458.
PMID: 38884724
DOI: 10.1007/978-3-031-44087-8_22.
Unlocking ovarian cancer heterogeneity: advancing immunotherapy through single-cell transcriptomics.
Balan D, Kampan N, Plebanski M, Abd Aziz N
Front Oncol. 2024; 14:1388663.
PMID: 38873253
PMC: 11169633.
DOI: 10.3389/fonc.2024.1388663.
Construction of a prognostic model with CAFs for predicting the prognosis and immunotherapeutic response of lung squamous cell carcinoma.
Zhang X, Xiao Q, Zhang C, Zhou Q, Xu T
J Cell Mol Med. 2024; 28(8):e18262.
PMID: 38520221
PMC: 10960179.
DOI: 10.1111/jcmm.18262.
Cancer Stem Cells: Current Challenges and Future Perspectives.
Vaseem Shaikh M, Custers S, Anand A, Miletic P, Venugopal C, Singh S
Methods Mol Biol. 2024; 2777:1-18.
PMID: 38478332
DOI: 10.1007/978-1-0716-3730-2_1.
scCensus: Off-target scRNA-seq reads reveal meaningful biology.
He D, Mount S, Patro R
bioRxiv. 2024; .
PMID: 38352549
PMC: 10862729.
DOI: 10.1101/2024.01.29.577807.
Single-Cell Transcriptome Analysis of Acute Myeloid Leukemia Cells Using Methanol Fixation and Cryopreservation.
Madaci L, Gard C, Nin S, Sarrabay A, Baier C, Venton G
Diseases. 2024; 12(1).
PMID: 38275564
PMC: 10814800.
DOI: 10.3390/diseases12010001.
Heterogeneous Expression Patterns of the Minichromosome Maintenance Complex Members in Retinoblastoma Unveil Its Clinical Significance.
Tang J, Liu Y, Zhang Z, Ren Y, Ma Y, Wang Y
Invest Ophthalmol Vis Sci. 2024; 65(1):31.
PMID: 38231525
PMC: 10795548.
DOI: 10.1167/iovs.65.1.31.
The molecular landscape of neurological disorders: insights from single-cell RNA sequencing in neurology and neurosurgery.
Awuah W, Ahluwalia A, Ghosh S, Roy S, Tan J, Adebusoye F
Eur J Med Res. 2023; 28(1):529.
PMID: 37974227
PMC: 10652629.
DOI: 10.1186/s40001-023-01504-w.
Advances in novel strategies for isolation, characterization, and analysis of CTCs and ctDNA.
Naei V, Bordhan P, Mirakhorli F, Khorrami M, Shrestha J, Nazari H
Ther Adv Med Oncol. 2023; 15:17588359231192401.
PMID: 37692363
PMC: 10486235.
DOI: 10.1177/17588359231192401.
Deciphering cell-cell interactions and communication in the tumor microenvironment and unraveling intratumoral genetic heterogeneity via single-cell genomic sequencing.
Cao Y, Ding J, Tang Q, Zhang J, Huang Z, Tang X
Bioengineered. 2023; 13(7-12):14974-14986.
PMID: 37105769
PMC: 10234225.
DOI: 10.1080/21655979.2023.2185434.
Benchmarking of analytical combinations for COVID-19 outcome prediction using single-cell RNA sequencing data.
Cao Y, Ghazanfar S, Yang P, Yang J
Brief Bioinform. 2023; 24(3).
PMID: 37096588
PMC: 10199760.
DOI: 10.1093/bib/bbad159.
Geographically weighted linear combination test for gene-set analysis of a continuous spatial phenotype as applied to intratumor heterogeneity.
Amini P, Hajihosseini M, Pyne S, Dinu I
Front Cell Dev Biol. 2023; 11:1065586.
PMID: 36998245
PMC: 10044624.
DOI: 10.3389/fcell.2023.1065586.
Single-cell profiling to explore pancreatic cancer heterogeneity, plasticity and response to therapy.
Barthel S, Falcomata C, Rad R, Theis F, Saur D
Nat Cancer. 2023; 4(4):454-467.
PMID: 36959420
PMC: 7615362.
DOI: 10.1038/s43018-023-00526-x.